{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-001636","form_type":"8-K","ticker":null,"cik":"0001602078","company_name":"Nemaura Medical Inc.","filed_at":"2023-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.728630+00:00","generated_at":"2026-06-07T22:41:18.467035+00:00","sec_items":["2.03","1.01","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nemaura Medical secures $10M credit facility with Streeterville Capital, non-dilutive funding for growth","bullets":["Line of credit facility for up to $10M from Streeterville Capital; maximum draw of $1M per month.","Monitoring fee of 0.8333% per month on outstanding draws; 20% original issue discount added per draw.","Facility secured by all assets of Nemaura, Dermal Diagnostics, and Trial Clinic.","Management states structure minimizes dilution compared to equity sales, supporting commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-001636","json":"https://secwatch.observer/filing/0001079973-23-001636.json","markdown":"https://secwatch.observer/filing/0001079973-23-001636.md","text":"https://secwatch.observer/filing/0001079973-23-001636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/0001079973-23-001636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/nmra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:41:18.467035+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f22fb67326ec43664f044d5b11c4395e76f26156","claim":"Nemaura Medical Inc. incurred credit facility of $10,000,000 with Streeterville Capital, LLC at 0.8333% per month maturing one year from the execution date of the LOC Agreement.","evidence_excerpt":"credit (the “Line of Credit”) to the Borrower and to make advances to the Borrower from time to time, which amounts will not exceed at any time the aggregate principal amount of $10,000,000 (the “Maximum Loan Amount”), unless Streeterville agrees, in its sole discretion, to extend additional amounts of credit under the LOC Agreement. Subject to the terms and","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/0001079973-23-001636-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$10,000,000"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Rate","value":"0.8333% per month"},{"label":"Maturity","value":"one year from the execution date of the LOC Agreement"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}